JC

Julie Cherrington

Venture Partner at Brandon Capital Partners

San Francisco, California

Overview 

Julie Cherrington is a highly accomplished Biotechnology Executive based in San Francisco, California, currently serving as a Board Member for Elevation Oncology and Chairperson of the Board for Tolremo Therapeutics. With a strong background in medicine and significant experience in biomarker discovery, her career highlights include roles as a Board Member for Syncona Limited and a Venture Partner at Brandon Capital Partners.

Work Experience 

  • Board Member

    2024 - Current

Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.

Raised $197,500,000.00 from K2 HealthVentures.

  • Chairperson of the Board

    2023

  • Chairperson of the Board

    2022

Actym Therapeutics is a biotech company that focuses on the discovery and development of novel immuno-oncology therapies to treat cancer.

Raised $59,500,000.00 from Boehringer Ingelheim Venture Fund, Panacea Venture, JLo Ventures, Illumina Ventures, GKCC, Korea Investment Partners, Illumina Ventures, JLo Ventures, Boehringer Ingelheim Venture Fund and Panacea Venture.

  • Board Member

    2022

  • Board Member

    2021

Sardona Therapeutics is a Scaling New Peaks in Cancer Therapy.

  • Venture Partner

    2022

  • Strategic Advisor

    2013

  • Board Member

    2022 - 2024

  • Board Member

    2021 - 2024

  • Board Member

    2019 - 2024

    Mirati acquired by BMS

Mirati Therapeutics is a Biotechnology company located in 9363 Towne Centre Dr, San Diego, CA, United States.

Raised $2,574,300,000.00.

Articles About Julie

Relevant Websites